Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cost Sharing | 15 | 2017 | 409 | 2.980 |
Why?
|
Medicare Part D | 10 | 2016 | 355 | 2.440 |
Why?
|
Risk Adjustment | 6 | 2013 | 599 | 1.320 |
Why?
|
Health Maintenance Organizations | 10 | 2016 | 657 | 1.320 |
Why?
|
Insurance Coverage | 10 | 2021 | 1946 | 1.130 |
Why?
|
California | 22 | 2017 | 1438 | 1.090 |
Why?
|
Medicare | 21 | 2017 | 6809 | 1.080 |
Why?
|
Personnel Turnover | 2 | 2017 | 89 | 1.040 |
Why?
|
Delivery of Health Care, Integrated | 10 | 2013 | 951 | 0.990 |
Why?
|
Deductibles and Coinsurance | 5 | 2012 | 315 | 0.950 |
Why?
|
Financing, Personal | 7 | 2012 | 310 | 0.860 |
Why?
|
Health Benefit Plans, Employee | 4 | 2012 | 332 | 0.850 |
Why?
|
Managed Care Programs | 6 | 2017 | 939 | 0.850 |
Why?
|
Medicare Part C | 4 | 2016 | 332 | 0.750 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2012 | 4055 | 0.700 |
Why?
|
Insurance, Health | 8 | 2021 | 2517 | 0.680 |
Why?
|
Insurance, Pharmaceutical Services | 3 | 2008 | 348 | 0.640 |
Why?
|
Office Visits | 3 | 2013 | 595 | 0.620 |
Why?
|
Drug Costs | 5 | 2013 | 1195 | 0.620 |
Why?
|
Health Expenditures | 7 | 2017 | 2389 | 0.610 |
Why?
|
Drugs, Generic | 3 | 2016 | 455 | 0.600 |
Why?
|
Electronic Health Records | 7 | 2015 | 4887 | 0.570 |
Why?
|
Preventive Health Services | 2 | 2012 | 570 | 0.570 |
Why?
|
Insurance Benefits | 2 | 2011 | 185 | 0.550 |
Why?
|
Insurance Selection Bias | 2 | 2012 | 69 | 0.450 |
Why?
|
Patient Compliance | 4 | 2008 | 2697 | 0.440 |
Why?
|
Emergency Service, Hospital | 7 | 2015 | 7951 | 0.440 |
Why?
|
United States | 37 | 2021 | 73039 | 0.430 |
Why?
|
Risperidone | 1 | 2016 | 383 | 0.430 |
Why?
|
Information Seeking Behavior | 1 | 2014 | 116 | 0.430 |
Why?
|
Drug Utilization | 3 | 2008 | 1189 | 0.420 |
Why?
|
Medical Savings Accounts | 1 | 2012 | 34 | 0.400 |
Why?
|
Insurance, Medigap | 2 | 2009 | 20 | 0.390 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2012 | 72 | 0.390 |
Why?
|
Patient Protection and Affordable Care Act | 4 | 2021 | 1188 | 0.380 |
Why?
|
Competitive Medical Plans | 1 | 2011 | 26 | 0.380 |
Why?
|
Choice Behavior | 3 | 2015 | 848 | 0.380 |
Why?
|
Health Planning | 1 | 2012 | 233 | 0.370 |
Why?
|
Antipsychotic Agents | 2 | 2016 | 3081 | 0.370 |
Why?
|
Patient Care | 2 | 2013 | 629 | 0.360 |
Why?
|
Poverty | 3 | 2014 | 2720 | 0.350 |
Why?
|
Fees, Pharmaceutical | 1 | 2009 | 66 | 0.340 |
Why?
|
Health Care Reform | 3 | 2016 | 1256 | 0.330 |
Why?
|
Medically Uninsured | 3 | 2014 | 840 | 0.330 |
Why?
|
Patients | 1 | 2016 | 908 | 0.320 |
Why?
|
Attitude of Health Personnel | 3 | 2014 | 3929 | 0.320 |
Why?
|
Ambulatory Care | 6 | 2012 | 2783 | 0.320 |
Why?
|
Hospitalization | 6 | 2021 | 10840 | 0.300 |
Why?
|
Diabetes Mellitus | 5 | 2015 | 5889 | 0.300 |
Why?
|
Health Status Indicators | 2 | 2011 | 969 | 0.300 |
Why?
|
Quality Improvement | 4 | 2016 | 3857 | 0.290 |
Why?
|
Early Detection of Cancer | 3 | 2017 | 3239 | 0.290 |
Why?
|
Health Care Surveys | 6 | 2016 | 2434 | 0.290 |
Why?
|
Comparative Effectiveness Research | 2 | 2017 | 714 | 0.270 |
Why?
|
Aged | 38 | 2021 | 171504 | 0.270 |
Why?
|
Physician-Patient Relations | 4 | 2010 | 3269 | 0.270 |
Why?
|
Models, Organizational | 1 | 2010 | 548 | 0.270 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3251 | 0.270 |
Why?
|
Patient Care Management | 1 | 2009 | 303 | 0.270 |
Why?
|
Delivery of Health Care | 2 | 2017 | 5367 | 0.260 |
Why?
|
Personal Health Services | 1 | 2005 | 24 | 0.250 |
Why?
|
Interviews as Topic | 5 | 2013 | 2741 | 0.250 |
Why?
|
Mammography | 2 | 2016 | 2433 | 0.250 |
Why?
|
Prescription Fees | 2 | 2005 | 153 | 0.250 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1406 | 0.250 |
Why?
|
Male | 48 | 2017 | 364719 | 0.240 |
Why?
|
Female | 50 | 2017 | 397192 | 0.240 |
Why?
|
Benchmarking | 1 | 2011 | 1057 | 0.240 |
Why?
|
Primary Health Care | 6 | 2016 | 4746 | 0.240 |
Why?
|
Health Care Costs | 4 | 2012 | 3239 | 0.240 |
Why?
|
Patient Care Team | 2 | 2013 | 2523 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 5 | 2014 | 3231 | 0.240 |
Why?
|
Quality of Health Care | 3 | 2015 | 4310 | 0.240 |
Why?
|
Income | 5 | 2014 | 1878 | 0.240 |
Why?
|
Primary Prevention | 1 | 2012 | 1188 | 0.230 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2009 | 709 | 0.230 |
Why?
|
Attitude to Computers | 1 | 2005 | 196 | 0.230 |
Why?
|
Humans | 69 | 2021 | 768166 | 0.230 |
Why?
|
Reimbursement Mechanisms | 1 | 2009 | 670 | 0.230 |
Why?
|
Patient Readmission | 3 | 2015 | 3288 | 0.220 |
Why?
|
Anti-Asthmatic Agents | 1 | 2008 | 577 | 0.210 |
Why?
|
Medical Informatics Applications | 1 | 2005 | 180 | 0.210 |
Why?
|
Drug Prescriptions | 3 | 2011 | 1668 | 0.210 |
Why?
|
Aged, 80 and over | 18 | 2016 | 59629 | 0.200 |
Why?
|
Medical Informatics | 1 | 2009 | 743 | 0.200 |
Why?
|
Health Services | 1 | 2006 | 755 | 0.190 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11519 | 0.180 |
Why?
|
Middle Aged | 28 | 2017 | 223492 | 0.170 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 1886 | 0.160 |
Why?
|
Health Services Accessibility | 3 | 2014 | 5520 | 0.160 |
Why?
|
Educational Status | 3 | 2014 | 2515 | 0.160 |
Why?
|
Socioeconomic Factors | 7 | 2016 | 7852 | 0.160 |
Why?
|
Confidence Intervals | 3 | 2013 | 2923 | 0.160 |
Why?
|
Ambulatory Care Facilities | 2 | 2016 | 939 | 0.160 |
Why?
|
Physicians | 1 | 2017 | 4598 | 0.160 |
Why?
|
Emergency Medicine | 1 | 2008 | 1223 | 0.160 |
Why?
|
Adult | 26 | 2017 | 223646 | 0.160 |
Why?
|
Colonoscopy | 2 | 2017 | 1409 | 0.160 |
Why?
|
Denmark | 2 | 2011 | 776 | 0.150 |
Why?
|
Asthma | 3 | 2016 | 6291 | 0.150 |
Why?
|
Telemedicine | 2 | 2006 | 3109 | 0.150 |
Why?
|
Communication | 4 | 2010 | 3905 | 0.150 |
Why?
|
Chlorofluorocarbons | 1 | 2016 | 12 | 0.140 |
Why?
|
Colorectal Neoplasms | 4 | 2017 | 6974 | 0.140 |
Why?
|
Decision Making | 2 | 2008 | 3953 | 0.130 |
Why?
|
Patient Satisfaction | 3 | 2010 | 3488 | 0.130 |
Why?
|
Annual Reports as Topic | 1 | 2016 | 36 | 0.130 |
Why?
|
Program Evaluation | 2 | 2016 | 2507 | 0.130 |
Why?
|
Nebulizers and Vaporizers | 1 | 2016 | 139 | 0.130 |
Why?
|
Albuterol | 1 | 2016 | 211 | 0.130 |
Why?
|
Physicians, Family | 2 | 2010 | 349 | 0.120 |
Why?
|
Longitudinal Studies | 6 | 2015 | 14783 | 0.120 |
Why?
|
Information Services | 2 | 2006 | 239 | 0.110 |
Why?
|
Logistic Models | 5 | 2012 | 13290 | 0.110 |
Why?
|
Cohort Studies | 6 | 2016 | 41754 | 0.110 |
Why?
|
Medicaid | 2 | 2021 | 2840 | 0.110 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 64 | 0.110 |
Why?
|
Medication Adherence | 2 | 2016 | 2187 | 0.100 |
Why?
|
Mass Screening | 3 | 2017 | 5458 | 0.100 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8054 | 0.100 |
Why?
|
Adolescent | 12 | 2016 | 89169 | 0.100 |
Why?
|
Multivariate Analysis | 4 | 2013 | 12077 | 0.100 |
Why?
|
Hypertension | 3 | 2011 | 8616 | 0.100 |
Why?
|
Comorbidity | 2 | 2021 | 10590 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 713 | 0.100 |
Why?
|
Cost Savings | 1 | 2017 | 904 | 0.100 |
Why?
|
Endocarditis, Bacterial | 1 | 2015 | 436 | 0.090 |
Why?
|
Models, Economic | 1 | 2015 | 719 | 0.090 |
Why?
|
Hypoglycemic Agents | 3 | 2012 | 3109 | 0.090 |
Why?
|
Blood Pressure | 1 | 2007 | 8543 | 0.090 |
Why?
|
Economic Recession | 1 | 2012 | 79 | 0.090 |
Why?
|
Biosurveillance | 1 | 2011 | 16 | 0.090 |
Why?
|
Disease Outbreaks | 2 | 2011 | 1761 | 0.090 |
Why?
|
Costs and Cost Analysis | 2 | 2015 | 1667 | 0.090 |
Why?
|
Unemployment | 1 | 2012 | 211 | 0.090 |
Why?
|
Medical Staff | 1 | 2010 | 40 | 0.090 |
Why?
|
Medical Order Entry Systems | 1 | 2015 | 524 | 0.090 |
Why?
|
Cross-Sectional Studies | 6 | 2010 | 26379 | 0.080 |
Why?
|
Quality Indicators, Health Care | 2 | 2010 | 1805 | 0.080 |
Why?
|
Consumer Health Information | 1 | 2012 | 215 | 0.080 |
Why?
|
Quality Assurance, Health Care | 2 | 2010 | 2176 | 0.080 |
Why?
|
Public Health Informatics | 1 | 2010 | 109 | 0.080 |
Why?
|
Young Adult | 8 | 2016 | 60066 | 0.080 |
Why?
|
Child Health Services | 1 | 2014 | 645 | 0.080 |
Why?
|
Financing, Government | 1 | 2012 | 473 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2015 | 635 | 0.080 |
Why?
|
Health Status | 3 | 2016 | 4091 | 0.080 |
Why?
|
Internet | 2 | 2014 | 3110 | 0.070 |
Why?
|
Certification | 1 | 2011 | 420 | 0.070 |
Why?
|
Hospitals, University | 1 | 2010 | 570 | 0.070 |
Why?
|
Tartrates | 1 | 2007 | 13 | 0.070 |
Why?
|
Taxes | 1 | 2010 | 220 | 0.070 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 388 | 0.070 |
Why?
|
Sentinel Surveillance | 1 | 2010 | 292 | 0.070 |
Why?
|
Observation | 1 | 2009 | 310 | 0.070 |
Why?
|
Adrenergic Antagonists | 1 | 2007 | 26 | 0.070 |
Why?
|
Cost Control | 1 | 2010 | 627 | 0.070 |
Why?
|
Thiazides | 1 | 2007 | 19 | 0.070 |
Why?
|
Continuity of Patient Care | 1 | 2014 | 1078 | 0.070 |
Why?
|
New York City | 1 | 2010 | 737 | 0.070 |
Why?
|
Patient Preference | 1 | 2015 | 946 | 0.070 |
Why?
|
Professional Role | 1 | 2010 | 316 | 0.070 |
Why?
|
Atenolol | 1 | 2007 | 99 | 0.070 |
Why?
|
Metoprolol | 1 | 2007 | 90 | 0.070 |
Why?
|
Family Practice | 1 | 2009 | 509 | 0.070 |
Why?
|
Propanolamines | 1 | 2007 | 164 | 0.070 |
Why?
|
Sex Distribution | 2 | 2015 | 2278 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1514 | 0.070 |
Why?
|
Hypolipidemic Agents | 2 | 2012 | 609 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15662 | 0.070 |
Why?
|
Child, Preschool | 6 | 2016 | 42669 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1662 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 620 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2080 | 0.060 |
Why?
|
Carbazoles | 1 | 2007 | 230 | 0.060 |
Why?
|
Efficiency, Organizational | 1 | 2010 | 697 | 0.060 |
Why?
|
Outpatients | 1 | 2013 | 1600 | 0.060 |
Why?
|
Prepaid Health Plans | 1 | 2004 | 9 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2012 | 2732 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2008 | 1169 | 0.060 |
Why?
|
Poisson Distribution | 1 | 2006 | 506 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2357 | 0.060 |
Why?
|
Pharmaceutical Services | 1 | 2006 | 143 | 0.060 |
Why?
|
Self Administration | 1 | 2005 | 386 | 0.060 |
Why?
|
Clinical Competence | 2 | 2010 | 4858 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 614 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4260 | 0.060 |
Why?
|
Infant | 4 | 2013 | 36535 | 0.060 |
Why?
|
Regression Analysis | 3 | 2012 | 6340 | 0.050 |
Why?
|
Odds Ratio | 2 | 2007 | 9669 | 0.050 |
Why?
|
Population Surveillance | 1 | 2013 | 2596 | 0.050 |
Why?
|
Medical Records Systems, Computerized | 1 | 2009 | 1196 | 0.050 |
Why?
|
Databases, Factual | 4 | 2012 | 8080 | 0.050 |
Why?
|
Computers | 1 | 2005 | 592 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3479 | 0.050 |
Why?
|
Internal Medicine | 1 | 2009 | 1064 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2006 | 443 | 0.050 |
Why?
|
Hospitals | 1 | 2015 | 3886 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8748 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2007 | 1243 | 0.050 |
Why?
|
Stroke | 2 | 2015 | 9755 | 0.050 |
Why?
|
Insurance Claim Review | 2 | 2016 | 744 | 0.050 |
Why?
|
Qualitative Research | 1 | 2012 | 3140 | 0.050 |
Why?
|
Space-Time Clustering | 2 | 2011 | 45 | 0.040 |
Why?
|
Child | 6 | 2016 | 80917 | 0.040 |
Why?
|
Age Distribution | 1 | 2006 | 2873 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2007 | 6316 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2015 | 5349 | 0.040 |
Why?
|
Influenza, Human | 1 | 2011 | 1541 | 0.040 |
Why?
|
Time Factors | 4 | 2011 | 40218 | 0.040 |
Why?
|
Health Services Research | 1 | 2006 | 1815 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6229 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1951 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2016 | 21206 | 0.040 |
Why?
|
Length of Stay | 1 | 2011 | 6498 | 0.040 |
Why?
|
Risk Assessment | 2 | 2016 | 24315 | 0.040 |
Why?
|
Health Policy | 1 | 2010 | 2698 | 0.040 |
Why?
|
Registries | 1 | 2013 | 8375 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3252 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2029 | 0.030 |
Why?
|
Soil | 1 | 2016 | 120 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2013 | 5130 | 0.030 |
Why?
|
Attitude to Health | 1 | 2004 | 2025 | 0.030 |
Why?
|
Proxy | 1 | 2016 | 150 | 0.030 |
Why?
|
Heart Failure | 2 | 2011 | 11879 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5536 | 0.030 |
Why?
|
Mortality | 1 | 2006 | 2911 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20227 | 0.030 |
Why?
|
Computers, Handheld | 1 | 2016 | 211 | 0.030 |
Why?
|
Cholesterol, LDL | 2 | 2015 | 2403 | 0.030 |
Why?
|
Schizophrenia | 1 | 2013 | 6983 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2004 | 1444 | 0.030 |
Why?
|
Medical Record Linkage | 1 | 2015 | 286 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2015 | 445 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11101 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2006 | 3800 | 0.030 |
Why?
|
Algorithms | 2 | 2011 | 14164 | 0.030 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 320 | 0.030 |
Why?
|
Health Behavior | 1 | 2004 | 2650 | 0.020 |
Why?
|
Sex Factors | 2 | 2015 | 10632 | 0.020 |
Why?
|
SEER Program | 1 | 2015 | 1444 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2015 | 937 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2015 | 1165 | 0.020 |
Why?
|
Minnesota | 1 | 2010 | 339 | 0.020 |
Why?
|
Insurance Carriers | 1 | 2011 | 159 | 0.020 |
Why?
|
Texas | 1 | 2010 | 410 | 0.020 |
Why?
|
Neurology | 1 | 2016 | 786 | 0.020 |
Why?
|
Age Factors | 2 | 2015 | 18412 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2016 | 81762 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21538 | 0.020 |
Why?
|
Risk Factors | 2 | 2012 | 74944 | 0.020 |
Why?
|
Urban Health | 1 | 2010 | 535 | 0.020 |
Why?
|
Aluminum | 1 | 2007 | 150 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2011 | 65371 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2012 | 964 | 0.020 |
Why?
|
Cross Infection | 1 | 2015 | 1426 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2011 | 877 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2011 | 810 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2006 | 26422 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1259 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5315 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2862 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3773 | 0.010 |
Why?
|
Episode of Care | 1 | 2005 | 127 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 2010 | 772 | 0.010 |
Why?
|
Syndrome | 1 | 2010 | 3272 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10101 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8890 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 54926 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 12252 | 0.010 |
Why?
|
Parents | 1 | 2014 | 3595 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5884 | 0.010 |
Why?
|
Trust | 1 | 2004 | 532 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2235 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4860 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2011 | 1947 | 0.010 |
Why?
|
Pneumonia | 1 | 2011 | 2163 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2011 | 3073 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6283 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9374 | 0.010 |
Why?
|
Information Dissemination | 1 | 2004 | 1143 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 13490 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12543 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 9384 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39348 | 0.000 |
Why?
|